[HTML][HTML] Olaparib plus bevacizumab as first-line maintenance in ovarian cancer

I Ray-Coquard, P Pautier, S Pignata… - … England Journal of …, 2019 - Mass Medical Soc
Background Olaparib has shown significant clinical benefit as maintenance therapy in
women with newly diagnosed advanced ovarian cancer with a BRCA mutation. The effect of …

[HTML][HTML] ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post …

I Chebouti, JD Kuhlmann, P Buderath, S Weber… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background We recently showed that the presence of ERCC1+ CTCs is an independent
predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal …

Postural and gait performance in children with attention deficit/hyperactivity disorder

P Buderath, K Gärtner, M Frings, H Christiansen… - Gait & posture, 2009 - Elsevier
Up to 50% of children and adolescents with attention deficit/hyperactivity disorder (ADHD)
exhibit motor abnormalities including altered balance. Results from brain imaging studies …

ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance

JD Kuhlmann, P Wimberger, A Bankfalvi… - Clinical …, 2014 - academic.oup.com
BACKGROUND Platinum resistance constitutes one of the most recognized clinical
challenges for ovarian cancer. Notably, the detection of the primary tumor-based excision …

Balance and motor speech impairment in essential tremor

M Kronenbuerger, J Konczak, W Ziegler, P Buderath… - The Cerebellum, 2009 - Springer
The pathogenesis of essential tremor (ET) is still under debate. Several lines of evidence
indicate that ET is associated with cerebellar dysfunction. The aim of the present study was …

[18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results

K Beiderwellen, J Grueneisen, V Ruhlmann… - European journal of …, 2015 - Springer
Purpose To evaluate the diagnostic potential of PET/MRI with [18 F] FDG in recurrent
ovarian and cervical cancer in comparison to PET/CT. Methods A group of 19 patients with …

[HTML][HTML] EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

I Chebouti, S Kasimir-Bauer, P Buderath… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Assuming that tumor cell dissemination requires a shift to a mesenchymal
phenotype, we analyzed the incidence of epithelial-to-mesenchymal-transition (EMT)-like …

[HTML][HTML] Soluble programmed death receptor ligands sPD-L1 and sPD-L2 as liquid biopsy markers for prognosis and platinum response in epithelial ovarian cancer

P Buderath, E Schwich, C Jensen, PA Horn… - Frontiers in …, 2019 - frontiersin.org
Introduction: Response to platinum-based therapy is a major prognostic factor in epithelial
ovarian cancer (EOC) and reliable prognostic biomarkers are urgently needed to identify …

[HTML][HTML] Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer

J Grueneisen, K Beiderwellen, P Heusch, P Buderath… - PLoS …, 2014 - journals.plos.org
Background To evaluate a potential correlation of the maximum standard uptake value
(SUVmax) and the minimum apparent diffusion coefficient (ADCmin) in primary and …

ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer

L Giannopoulou, S Mastoraki, P Buderath, A Strati… - Gynecologic …, 2018 - Elsevier
Objective Estrogen receptor, coded by the ESR1 gene, is highly expressed in epithelial
ovarian cancer. ESR1 gene is frequently methylated in many types of gynecological …